FCG Investment Company Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$1.34M |
| 2 |
Mastercard
MA
|
+$1.18M |
| 3 |
Stellantis
STLA
|
+$965K |
| 4 |
GE Aerospace
GE
|
+$807K |
| 5 |
Amazon
AMZN
|
+$803K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.8M |
| 2 |
Super Micro Computer
SMCI
|
+$1.93M |
| 3 |
IBM
IBM
|
+$1.25M |
| 4 |
Visa
V
|
+$1.05M |
| 5 |
Broadcom
AVGO
|
+$804K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.77% |
| 2 | Healthcare | 11.02% |
| 3 | Consumer Discretionary | 9.69% |
| 4 | Financials | 9.66% |
| 5 | Communication Services | 8.22% |
Similar funds
FCG Investment Company's Q1 2024 Portfolio in Review
As of Q1 2024, FCG Investment Company held 102 positions worth $125M, up 23% from $102M the previous quarter. Its ten largest holdings account for 38% of the portfolio.
FCG Investment Company deployed $6.79M of net new capital in Q1 2024, opening 12 new positions and adding to 58 existing holdings. Its largest new stake was AbbVie: 7,762 shares worth $1.41M.
By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 32% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $5.8M trimmed.
- FCG Investment Company's largest Q1 2024 buy was AbbVie: 7,762 shares worth $1.41M.
- FCG Investment Company added most to Mastercard in Q1 2024, an estimated $1.18M increase.
- FCG Investment Company's biggest Q1 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.8M.
- FCG Investment Company fully exited Nucor in Q1 2024, selling an estimated $361K.
- FCG Investment Company's ten largest holdings make up 38% of its $125M portfolio in Q1 2024.
- FCG Investment Company opened 12 new positions and closed 2 in Q1 2024.
- FCG Investment Company's portfolio value rose 23% quarter-over-quarter to $125M.
Based on FCG Investment Company's 13F filing for Q1 2024, filed 19 Apr 2024.